Ayurveda is a traditional medical system of India. In Ayurveda, Panchakarma (fivefold detoxification treatment) procedures are designed for internal purification and cleansing. As per the Indian government's initiative (launched in September 2014), Ayurveda is part of wellness industry. There is a constant rise in the number of Ayurveda clinics, hospitals, wellness centers, and spas in India. The various Panchakarma procedures performed in these hospitals, clinics, wellness centers, and spas generate biomedical wastes (BMW). Metropolitan areas in India bring about 62 million tonnes of wastes annually, and this figure is predicted to rise to 165 million tonnes by 2030. Forty-three million tonnes of the municipal solid waste are collected every year, of which 31 million are disposed of in landfills and only 11.9 million are treated. Pharmaceutical wastes are one among them. Reports from the Indian medicinal plant industries indicate that presently more than 9000 plant industries are registered in India, which produces a huge amount of waste each year. This has created a need in the proper management of waste generated. Here is the description and discussion of categorization, classification, and treatment options for waste generated during Panchakarma procedures in Ayurveda hospitals. Effective and proper management of the BMW is necessary to maintain personal as well as environmental health. The current available techniques for the treatment of waste generated during Panchakarma procedure are sewage drainage, incineration, and landfill. Nothing turns around to be waste until it is being not used further with intelligence. The natural cycles of life taught us the same through science: utilizing of three Rs of ideal waste management. While further advancement can include the use of phytoremediation, composting, vermicomposting, biofiltration, bioaugmentation and use of solar energy in waste management.

Granulomatosis with polyangiitis (GPA) was formerly known as Wegener’s granulomatosis. As its name implies, the disease is associated with a necrotizing granulomatous inflammation with vasculitis of small and medium blood vessels induced by antineutrophil cytoplasmic antibodies (ANCA). Here, we present a case of a 42-year-old woman with severe arthralgia associated with fever and obstructive uropathy. Blood investigations revealed a high level of C-ANCA, C-reactive protein, erythrocyte sedimentation rate, and reduced hemoglobin level. She had a history of rheumatic heart disease in the childhood. The patient was treated with Ayurvedic oral drugs for 3 months. After 1 month of follow-up period, the patient showed a significant improvement in presenting symptoms as well as laboratory investigations. There was a significant reduction in swelling and tenderness over both ankle joints. Presently, the patient is stable with Ayurvedic medications. The case study shows a ray of hope toward the management of GPA with holistic Ayurveda medications with satisfactory outcome and contentment of the patient. However, more studies should be observed for definite conclusion.

No abstract

Background: Bell's palsy is an acute idiopathic condition that develops due to peripheral facial nerve paralysis of sudden onset, usually affecting the face by temporary weakness or paralysis of the face. With various aetiologies (infection, trauma, ischemia, or inflammation) affecting the seventh cranial nerve are the pathogenesis to originating the symptoms of Bells's palsy. According to Ayurveda, this condition can be correlated with Ardita Vata, which is described under the umbrella of Vatavyadhi Chikitsa. Aim and Objectives: The study has been documented to evaluate the efficacy of Panchakarma procedures along with Shamana Aushadhi (oral medication) in the management of a patient with chronic Bell's palsy. Settings: A 1-year-old chronic case of Bell's palsy was managed in out patient department-based Panchakarma treatment at AIIA, New Delhi, and the patient was assessed both before and after the given treatment. Treatment Plan: The patient was administered Mukhabhyanga (massage on face) with Asana Bilwadi Taila, Nadi Sweda (sudation) with Dashamoola Ksheer Dhooma, Nasya (transnasal medication) with Avartita Ksheerbala Taila in Arohana Matra (increasing dose), and Kavala (Gargling) with Saindhavadi Taila and Irimedadi Taila for 14 days along with Shamana medication for one month. Result: Marked improvement was observed on the basis of House–Brackmann scale; continuous teardrops from the eye were completely stopped. After 15 days of treatment, the scale was reduced from IV to III, and then II, I, respectively after the 30th day and 60th day during the follow-up. Conclusion: This case showed promising and quick results of Ayurveda treatment by considering aspects of Vatavyadhi, specifically Ardita Vata, even after 1 year of chronicity without showing any complications.

Background: Prediabetes is a pathological condition that is characterized by an increase in sugar level within the normal limit and a diagnostic range of diabetes mellitus (DM). Timely untreated prediabetes turns into DM within a year and systemic complications occur, such as retinopathy, nephropathy, neuropathy, etc. During later stages of the disease, all systems of the body are affected. The management of prediabetes includes oral hypoglycemic drugs. Based on signs and symptoms, prediabetes can be correlated to the disease Prameha. Aim and Objectives: Evaluate the efficacy of oral administration of Darvyadi Kwatha (~herbal decoction) with lifestyle modification in prediabetes (Prameha). Materials and Methods: After the approval of Institutional Review Board, Independent Ethics Committee, and clinical trial registration in CTRI, 20 patients suffering with Prameha (~prediabetes) were registered in the clinical trial. Assessment criteria were: reduction in glycated hemoglobin (HBA1c), fasting plasma glucose (FBS), postprandial plasma glucose (PPBS), improvement in Agnibala (~strength of digestion and metabolism), Dehabala (~physical strength), and Satvabala (~mental strength), relief in signs and symptoms of prediabetes, and improvement in quality of life (SF-36 Score). Oral administration of Darvyadi Kwatha and lifestyle modification was given. Assessment was done on the 46th, 76th, 107th, and 120th day and Student paired t-test was used for analysis of data. Results: The outcomes showed a statistically highly significant reduction in assessment parameters (HBA1c [mean ± standard deviation [SD] before treatment [BT] 6.07 ± 0.26 and after treatment [AT] 5.78 ± 0.22] [<0.001], FBS [mean ± SD BT 116.6 ± 12.5 and AT 102.0 ± 0.8.1] [<0.001], and PPBS [mean ± SD BT 168.7 ± 19.7 and AT 118.6 ± 12.0] [<0.001]). Conclusion: This clinical study concludes that Ayurveda medicine (Darvyadi Kwatha and lifestyle modification) is effective in the treatment and prevention of prediabetes turning into DM.